ClinicalTrials.gg
Sign In

Cholecystitis, Acute clinical trials

The registry lists 140 studies for Cholecystitis, Acute across more than 10 countries. 30 are recruiting or about to start. 120 of them are mainly about Cholecystitis, Acute (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20.

Get an email when these change. Save the Cholecystitis, Acute studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
85
Status unknown
20
Recruiting
20
Not yet recruiting
9
Withdrawn
3
Terminated
2

Phase

Phase 3
8
Phase 4
6
Phase 2
3
Phase 1
1

Where

United States
16
Spain
13
Italy
13
Korea, Republic of
13
Turkey
11
Egypt
10

Who runs them

Hospital del Mar (6) · Peking Union Medical College Hospital (4) · Seoul St. Mary's Hospital (4) · Karolinska Institutet (4) · Chinese University of Hong Kong (4) · Medipol University (3) · Assiut University (3) · Yonsei University (3)

What is being tested here

Drugs under test in Cholecystitis, Acute studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bupivacaine102
Remimazolam002
Allogeneic Ex-vivo-treated Peripheral Blood Mononuclear Cells001
Glycopyrrolate001
Cephalosporins001
Moxifloxacin011
Ascorbic Acid001
Indocyanine Green001
Ursodeoxycholic Acid011

Coming up

1phase 3 study under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 20 Cholecystitis, Acute studies recruiting now, 16 (80%) set no upper age limit and 2 (10%) stop at 75 or younger. 2 (10%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 20
AgeWomenMen
102 (10%)2 (10%)
1816 (80%)16 (80%)
3018 (90%)18 (90%)
4018 (90%)18 (90%)
5018 (90%)18 (90%)
6517 (85%)17 (85%)
7518 (90%)18 (90%)
8518 (90%)18 (90%)

Across all 140 studies, recruiting or not: 22% stop at 75 or younger and 14% at 65; 15% take children; 1% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Cholecystitis, Acute studies take

Of 45 interventional studies with no phase under Cholecystitis, Acute, half reached primary completion within 20 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase20 mo9–27 · 45 studies—18 mo9–24 · 42 studies
Observational20 mo11–42 · 22 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 140. Browse all 140 → or search them.